State Street
OBIO icon

State Street’s Orchestra BioMed OBIO Stock Holding History

State Street’s Portfolio OBIO Stock Details OBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.77M Buy
605,778
+89,728
+17% +$430K ﹤0.01% 3185
2026
Q2 		$2.23M Buy
516,050
+346,640
+205% +$1.42M ﹤0.01% 3362
2026
Q1 		$720K Buy
169,410
+10,377
+7% +$44.2K ﹤0.01% 3565
2025
Q4 		$660K Buy
159,033
+58,300
+58% +$235K ﹤0.01% 3613
2025
Q3 		$250K Sell
100,733
-29,400
-23% -$81.1K ﹤0.01% 3844
2025
Q2 		$349K Sell
130,133
-343,586
-73% -$1M ﹤0.01% 3694
2025
Q1 		$2.03M Buy
473,719
+26,007
+6% +$129K ﹤0.01% 3244
2024
Q4 		$1.79M Buy
447,712
+18,099
+4% +$97.2K ﹤0.01% 3351
2024
Q3 		$2.21M Buy
429,613
+47,308
+12% +$309K ﹤0.01% 3297
2024
Q2 		$3.12M Buy
382,305
+127,358
+50% +$738K ﹤0.01% 3131
2024
Q1 		$1.34M Sell
254,947
-30,963
-11% -$210K ﹤0.01% 3397
2023
Q4 		$2.61M Buy
285,910
+106,029
+59% +$724K ﹤0.01% 3227
2023
Q3 		$1.57M Buy
179,881
+38,044
+27% +$256K ﹤0.01% 3418
2023
Q2 		$993K Buy
141,837
+107,651
+315% +$1.63M ﹤0.01% 3581
2023
Q1 		$669K Buy
+34,186
New +$396K ﹤0.01% 3651

Other funds holding OBIO

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
DMKJ
David M. Knott Jr $183M AUM 73.23% 1-Year Est. Return
Simplify Asset Management
Simplify Asset Management Las Vegas, Nevada $6.11B AUM 3.71% 1-Year Est. Return
Daytona Street Capital
Daytona Street Capital Saint Louis, Missouri $141M AUM 14.38% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
IFP Advisors
IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $113B AUM 26.61% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Holos Integrated Wealth
Holos Integrated Wealth Kennett Square, Pennsylvania $223M AUM 9.55% 1-Year Est. Return

State Street's OBIO Position: Q3 2026 in Review

State Street increased its Orchestra BioMed (OBIO) stake by 17% in Q3 2026, buying an estimated $430K and bringing the position to 605,778 shares worth $3.77M. The position accounts for ﹤0.01% of the portfolio, ranked #3185.

State Street first reported a position in OBIO in Q1 2023 and has held it in 15 quarters since. 43 funds tracked by Wall St. Rank hold OBIO as of Q3 2026.

  • State Street held 605,778 shares of Orchestra BioMed worth $3.77M as of Q3 2026.
  • State Street bought 89,728 Orchestra BioMed shares in Q3 2026, an estimated $430K.
  • Orchestra BioMed made up ﹤0.01% of State Street's portfolio in Q3 2026, its #3185 holding.
  • State Street first reported a position in Orchestra BioMed in Q1 2023 and has held it in 15 quarters since.
  • 43 funds tracked by Wall St. Rank held Orchestra BioMed as of Q3 2026.

Based on State Street's 13F filing for Q3 2026, filed 12 Nov 2026.